Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000016

CHIEF FINANCIAL OFFICER acquired 13,072 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Andrade Robert · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-26 Exercise or conversion : show line 1 in the form +13,072 $5.10 $66,667 256,656 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-26 Exercise or conversion : show line 2 in the form Stock Options −13,072 $5.10 $66,667 801,045 D
Loading xslF345X06/form4-03262026_080309.xml…